Cell line technology
By Frances Griss
One of the most exciting and rapidly growing fields of bioscience is the development of new cell lines with specific and controllable characteristics, either for research or industrial scale production.
Companies all over...
Understanding climate change and infectious disease: is the one health movement enough?
1 University of Reading, School of Agriculture, Policy and Development, Livestock Development Group
1&2 University of Reading, Walker Institute for Climate Research
In the coming decades, climate change is predicted to produce a range of direct...
NETPark: A Catalyst for Job Creation and Economic Prosperity
The year 2023 was a landmark year for the North East Technology Park (NETPark) at Sedgefield, as it embarked on a £61 million expansion, marking a significant milestone in its development.
This expansion, led by...
Crowdfunding: 21st century capital for startups and SMEs
Although Britain has long been recognised as a country of pioneering scientists, inventors and entrepreneurs, it has historically been poor at making sufficient capital available for this creativity to blossom fully to the UK’s...
Three-Parent Babies a step closer after regulations grant approval
Occasionally in the world of science, a breakthrough comes along that is so startling that it turns conventional thinking on its head.
That is the case with the latest research into the idea of three-person...
Unlocking the secrets of a killer
Scientists are making significant progress to improve the testing and treatment of the killer illness salmonella.
Achieving success is vital because every year almost one in ten people fall ill to food-borne illnesses, with many...
Changes in drug delivery open up commercial opportunities
After centuries of delivering drugs to patients as pills, liquids and injectables a revolution is under way which will change everything for patients - from the dose needed to the frequency of administration.
Life for...
Bacterial Biofilms: A game-changer in the battle against infection
Bacteria, those tiny, often-misunderstood microorganisms, have revealed a groundbreaking secret that could transform our approach to combating infections. Luiza Beirão Campos, of the European Science Communication Institute (ESCI), explains how.
Bacteria are notorious for banding...
Case Western Reserve University School of Medicine Researchers Create First Artificial Human Prion
Finding May Shed Added Light On, Offer Treatment Hope for Brain-Wasting Diseases
Case Western Reserve University School of Medicine researchers have synthesized the first artificial human prion, a dramatic development in efforts to combat a...
Cell therapy manufacturing
Regenerative medicine and cellular therapies have the potential to impact many different areas of unmet medical need. There are many human diseases which have either inadequate or no treatment options. One of the main...
More than £700m saved
The NHS has saved more than £700 million from the annual medicines bill to reinvest in new treatments as part of the Long Term Plan.
An NHS-wide campaign has supported patients and doctors to maximise...
Plant patentability and the European Patent Office – what is the latest update?
Plant patentability has long been a contentious issue throughout intellectual property and scientific circles.
The question as to whether plants or animals created through essentially biological processes, such as genetic or selective breeding, can be...
Driving innovation
As one of the leading technology transfer companies, UCLB’s mission is to benefit both the economy and society as a whole by commercialising the discoveries and developments that come out of UCL. The ‘B’...
Freedom to Operate – Understanding the Risks
There are many factors to be considered for a project developing a new product or process, but the ability to carry out commercial plans without infringing third party patent rights (freedom to operate, or...
Stay future-ready: Running parallel operations with a CDMO during clinical trials
Bringing a drug candidate through clinical trials is a challenging and high-risk process, since only 10% of candidates actually reach final approval. Both established pharma companies and small startups are often faced with this...
Biosimilars offering encouraging results in rheumatology
One of the other areas in which biosimilars are attracting attention is rheumatology and an example of new products coming online was highlighted at the recent Annual European Congress of Rheumatology in London.
Data demonstrating...